Document is current
Any future updates will be listed below
-
Authors
Mirmosayyeb, Omid
Zivadinov, Robert
Weinstock-Guttman, Bianca
Benedict, Ralph H. B.
Jakimovski, Dejan https://orcid.org/0000-0001-7114-4958
- License Information
-
More Information
Article History
Received: 9 August 2022
Revised: 21 October 2022
Accepted: 22 October 2022
First Online: 17 November 2022
Declarations
:
: The authors declare no conflict of interest regarding the publication of this paper. Omid Mirmosayyeb has nothing to disclose. Robert Zivadinov has received personal compensation from Bristol Myers Squibb, EMD Serono, Sanofi, Protembis, Janssen, 415 Capital, and Novartis for speaking and consultant fees. He received financial support for research activities from Sanofi, Novartis, Bristol Myers Squibb, Octave, Mapi Pharma, CorEvitas, Protembis and V-WAVE Medical. Bianca Weinstock-Guttman received honoraria as a speaker and/or as a consultant for Biogen Idec, Teva Pharmaceuticals, EMD Serono, Genzyme, Sanofi, Genentech, Novartis, Celgene/BMS, Janssen and Horizon Dr Weinstock-Guttman received research funds from Biogen Idec, EMD Serono, Genzyme, Genentech, Sanofi, Novartis. Ralph HB. Benedict has received consultation or speaking fees from Bristol Myer Squibb, Biogen, Merck, EMD Serono, Roche, Verasci, Immune Therapeutics, Novartis, and Sanofi-Genzyme. Dejan Jakimovski serves as Associate Editor of Clinical Neurology and Neurosurgery and compensated by Elsevier B.V.
